Conservation and Regulatory Associations of a Wide Affinity Range of Mouse Transcription Factor Binding Sites
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Primepcr™Assay Validation Report
PrimePCR™Assay Validation Report Gene Information Gene Name zinc finger protein 161 Gene Symbol Zfp161 Organism Mouse Gene Summary Description Not Available Gene Aliases ZF5 RefSeq Accession No. NC_000083.6, NT_039649.8 UniGene ID Mm.29434 Ensembl Gene ID ENSMUSG00000049672 Entrez Gene ID 22666 Assay Information Unique Assay ID qMmuCID0009626 Assay Type SYBR® Green Detected Coding Transcript(s) ENSMUST00000112674, ENSMUST00000062369, ENSMUST00000112676 Amplicon Context Sequence GATCAGCCTGAGTCTGATCTGAAGATTTTGGTGTTTAAGGCATTAAGAACATAGC CTGAATTGTTCATGGAGTTTTTCATCAGTATGTCTGAAACCATAAAATATAATGAT GATGATCATAAAACGCTGTTTCTGAAAACACTGAACGAACAGCGCCTGGAGGGA GAATTCTGCGACATCGCCATCGTGGTTGAAGATGTAAAGTTCCGAGCCCACCGG TGTGTCCTCGC Amplicon Length (bp) 200 Chromosome Location 17:69385436-69387472 Assay Design Intron-spanning Purification Desalted Validation Results Efficiency (%) 104 R2 0.9993 cDNA Cq 24.19 cDNA Tm (Celsius) 82 gDNA Cq 35.48 Specificity (%) 100 Information to assist with data interpretation is provided at the end of this report. Page 1/4 PrimePCR™Assay Validation Report Zfp161, Mouse Amplification Plot Amplification of cDNA generated from 25 ng of universal reference RNA Melt Peak Melt curve analysis of above amplification Standard Curve Standard curve generated using 20 million copies of template diluted 10-fold to 20 copies Page 2/4 PrimePCR™Assay Validation Report Products used to generate validation data Real-Time PCR Instrument CFX384 Real-Time PCR Detection System Reverse Transcription Reagent iScript™ Advanced cDNA Synthesis Kit for RT-qPCR Real-Time PCR Supermix SsoAdvanced™ SYBR® Green Supermix Experimental Sample qPCR Mouse Reference Total RNA Data Interpretation Unique Assay ID This is a unique identifier that can be used to identify the assay in the literature and online. Detected Coding Transcript(s) This is a list of the Ensembl transcript ID(s) that this assay will detect. Details for each transcript can be found on the Ensembl website at www.ensembl.org. -
Growth and Molecular Profile of Lung Cancer Cells Expressing Ectopic LKB1: Down-Regulation of the Phosphatidylinositol 3-Phosphate Kinase/PTEN Pathway1
[CANCER RESEARCH 63, 1382–1388, March 15, 2003] Growth and Molecular Profile of Lung Cancer Cells Expressing Ectopic LKB1: Down-Regulation of the Phosphatidylinositol 3-Phosphate Kinase/PTEN Pathway1 Ana I. Jimenez, Paloma Fernandez, Orlando Dominguez, Ana Dopazo, and Montserrat Sanchez-Cespedes2 Molecular Pathology Program [A. I. J., P. F., M. S-C.], Genomics Unit [O. D.], and Microarray Analysis Unit [A. D.], Spanish National Cancer Center, 28029 Madrid, Spain ABSTRACT the cell cycle in G1 (8, 9). However, the intrinsic mechanism by which LKB1 activity is regulated in cells and how it leads to the suppression Germ-line mutations in LKB1 gene cause the Peutz-Jeghers syndrome of cell growth is still unknown. It has been proposed that growth (PJS), a genetic disease with increased risk of malignancies. Recently, suppression by LKB1 is mediated through p21 in a p53-dependent LKB1-inactivating mutations have been identified in one-third of sporadic lung adenocarcinomas, indicating that LKB1 gene inactivation is critical in mechanism (7). In addition, it has been observed that LKB1 binds to tumors other than those of the PJS syndrome. However, the in vivo brahma-related gene 1 protein (BRG1) and this interaction is required substrates of LKB1 and its role in cancer development have not been for BRG1-induced growth arrest (10). Similar to what happens in the completely elucidated. Here we show that overexpression of wild-type PJS, Lkb1 heterozygous knockout mice show gastrointestinal hamar- LKB1 protein in A549 lung adenocarcinomas cells leads to cell-growth tomatous polyposis and frequent hepatocellular carcinomas (11, 12). suppression. To examine changes in gene expression profiles subsequent to Interestingly, the hamartomas, but not the malignant tumors, arising in exogenous wild-type LKB1 in A549 cells, we used cDNA microarrays. -
Triplet Repeat Length Bias and Variation in the Human Transcriptome
Triplet repeat length bias and variation in the human transcriptome Michael Mollaa,1,2, Arthur Delcherb,1, Shamil Sunyaevc, Charles Cantora,d,2, and Simon Kasifa,e aDepartment of Biomedical Engineering and dCenter for Advanced Biotechnology, Boston University, Boston, MA 02215; bCenter for Bioinformatics and Computational Biology, University of Maryland, College Park, MD 20742; cDepartment of Medicine, Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; and eCenter for Advanced Genomic Technology, Boston University, Boston, MA 02215 Contributed by Charles Cantor, July 6, 2009 (sent for review May 4, 2009) Length variation in short tandem repeats (STRs) is an important family including Huntington’s disease (10) and hereditary ataxias (11, 12). of DNA polymorphisms with numerous applications in genetics, All Huntington’s patients exhibit an expanded number of copies in medicine, forensics, and evolutionary analysis. Several major diseases the CAG tandem repeat subsequence in the N terminus of the have been associated with length variation of trinucleotide (triplet) huntingtin gene. Moreover, an increase in the repeat length is repeats including Huntington’s disease, hereditary ataxias and spi- anti-correlated to the onset age of the disease (13). Multiple other nobulbar muscular atrophy. Using the reference human genome, we diseases have also been associated with copy number variation of have catalogued all triplet repeats in genic regions. This data revealed tandem repeats (8, 14). Researchers have hypothesized that inap- a bias in noncoding DNA repeat lengths. It also enabled a survey of propriate repeat variation in coding regions could result in toxicity, repeat-length polymorphisms (RLPs) in human genomes and a com- incorrect folding, or aggregation of a protein. -
Molecular Effects of Isoflavone Supplementation Human Intervention Studies and Quantitative Models for Risk Assessment
Molecular effects of isoflavone supplementation Human intervention studies and quantitative models for risk assessment Vera van der Velpen Thesis committee Promotors Prof. Dr Pieter van ‘t Veer Professor of Nutritional Epidemiology Wageningen University Prof. Dr Evert G. Schouten Emeritus Professor of Epidemiology and Prevention Wageningen University Co-promotors Dr Anouk Geelen Assistant professor, Division of Human Nutrition Wageningen University Dr Lydia A. Afman Assistant professor, Division of Human Nutrition Wageningen University Other members Prof. Dr Jaap Keijer, Wageningen University Dr Hubert P.J.M. Noteborn, Netherlands Food en Consumer Product Safety Authority Prof. Dr Yvonne T. van der Schouw, UMC Utrecht Dr Wendy L. Hall, King’s College London This research was conducted under the auspices of the Graduate School VLAG (Advanced studies in Food Technology, Agrobiotechnology, Nutrition and Health Sciences). Molecular effects of isoflavone supplementation Human intervention studies and quantitative models for risk assessment Vera van der Velpen Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Friday 20 June 2014 at 13.30 p.m. in the Aula. Vera van der Velpen Molecular effects of isoflavone supplementation: Human intervention studies and quantitative models for risk assessment 154 pages PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in Dutch and English ISBN: 978-94-6173-952-0 ABSTRact Background: Risk assessment can potentially be improved by closely linked experiments in the disciplines of epidemiology and toxicology. -
Supp Material.Pdf
Supplementary Material for: Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Roger Pique-Regi1;y;∗, Jacob F. Degner 1;2;y;∗, Athma A. Pai1, Daniel J. Gaffney1;3, Yoav Gilad1;∗, Jonathan K. Pritchard1;3;∗ 1Department of Human Genetics, University of Chicago 2Committee on Genetics, Genomics and Systems Biology, University of Chicago 3Howard Hughes Medical Institute, University of Chicago yThese authors contributed equally. ∗To whom correspondence should be addressed: [email protected], [email protected], [email protected], [email protected] 1 Contents 1 Overview 3 2 Data sources and processing 4 2.1 PWM scanning. .4 2.2 Data for the prior. .5 2.3 Experimental data. .5 2.4 Models for experimental data. .6 3 The CENTIPEDE model 7 3.1 The model. .7 3.2 Implementation details. 11 4 Validation of the CENTIPEDE predicted TF-bound sites 12 4.1 Validation with ChIP-seq. 12 4.2 Relationship to other methods.................................... 19 4.3 Conservation as validation of the CENTIPEDE predictions. 20 5 Motif analysis 20 5.1 De novo motif discovery. 20 5.2 Identification of groups of overlapping motifs. 21 5.3 Novel words that have a match in existing protein binding microarray data . 22 5.4 GO analysis of putative gene-targets of each TF. 22 5.5 Co-occurrence analysis of binding locations for each TF. 23 5.6 Linear modeling of steady state mRNA levels. 24 5.7 Analysis of multi-tissue expression for TF target genes. 25 5.8 Estimating enrichment/depletion of histone modifications at TF binding locations. -
Characterizing Novel Interactions of Transcriptional Repressor Proteins BCL6 & BCL6B
Characterizing Novel Interactions of Transcriptional Repressor Proteins BCL6 & BCL6B by Geoffrey Graham Lundell-Smith A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Biochemistry University of Toronto © Copyright by Geoffrey Lundell-Smith, 2017 Characterizing Novel Interactions of Transcriptional Repression Proteins BCL6 and BCL6B Geoffrey Graham Lundell-Smith Masters of Science Department of Biochemistry University of Toronto 2016 Abstract B-cell Lymphoma 6 (BCL6) and its close homolog BCL6B encode proteins that are members of the BTB-Zinc Finger family of transcription factors. BCL6 plays an important role in regulating the differentiation and proliferation of B-cells during the adaptive immune response, and is also involved in T cell development and inflammation. BCL6 acts by repressing genes involved in DNA damage response during the affinity maturation of immunoglobulins, and the mis- expression of BCL6 can lead to diffuse large B-cell lymphoma. Although BCL6B shares high sequence similarity with BCL6, the functions of BCL6B are not well-characterized. I used BioID, an in vivo proximity-dependent labeling method, to identify novel BCL6 and BCL6B protein interactors and validated a number of these interactions with co-purification experiments. I also examined the evolutionary relationship between BCL6 and BCL6B and identified conserved residues in an important interaction interface that mediates corepressor binding and gene repression. ii Acknowledgments Thank you to my supervisor, Gil Privé for his mentorship, guidance, and advice, and for giving me the opportunity to work in his lab. Thanks to my committee members, Dr. John Rubinstein and Dr. Jeff Lee for their ideas, thoughts, and feedback during my Masters. -
Refinement of Regions with Allelic Loss on Chromosome 18P11.2 and 18Q12.2 in Esophageal Squamous Cell Carcinoma1
Vol. 6, 3565–3569, September 2000 Clinical Cancer Research 3565 Refinement of Regions with Allelic Loss on Chromosome 18p11.2 and 18q12.2 in Esophageal Squamous Cell Carcinoma1 Jayaprakash D. Karkera,2 Saleh Ayache,2 more frequently in African-Americans than in Caucasians, Rodman J. Ransome, Jr., Marvin A. Jackson, whereas adenocarcinoma is more prevalent among Caucasians Ahmed F. Elsayem, Rajagopalan Sridhar, (2). Tobacco and alcohol consumption represents major envi- ronmental risk factors for this malignancy (3), but the molecular Sevilla D. Detera-Wadleigh, and events leading to esophageal cancer and the genetic components 3 Robert G. Wadleigh that are mutated at the inception and course of the neoplasm are Medical Oncology Section, Department of Veterans Affairs Medical largely unknown. Unraveling the genetic factors could provide Center, Washington, DC 20422 [J. D. K., S. A., R. G. W.]; targets for the development of more effective therapeutic agents. Departments of Pathology [R. J. R., M. A. J.], Medicine [A. F. E.], A variety of tumor suppressor genes have been implicated and Radiation Therapy and Cancer Center [R. S.], Howard University, Washington, DC 20060; and National Institute of Mental Health, in esophageal cancer (4, 5). Chromosomal abnormalities and NIH, Bethesda, MD 20892 [S. D. D.] LOH4 in which random isolated markers are used have been associated with esophageal tumors (6, 7). Analysis of chromo- some 18 has focused mainly on 18q21, where two known tumor ABSTRACT suppressor genes, DCC (8) and DPC4 (9) have been mapped. Esophageal cancer ranks among the 10 most common However, only infrequent deletions of DCC and DPC4 have cancers worldwide and is almost invariably fatal. -
MOCHI Enables Discovery of Heterogeneous Interactome Modules in 3D Nucleome
Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press MOCHI enables discovery of heterogeneous interactome modules in 3D nucleome Dechao Tian1,# , Ruochi Zhang1,# , Yang Zhang1, Xiaopeng Zhu1, and Jian Ma1,* 1Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA #These two authors contributed equally *Correspondence: [email protected] Contact To whom correspondence should be addressed: Jian Ma School of Computer Science Carnegie Mellon University 7705 Gates-Hillman Complex 5000 Forbes Avenue Pittsburgh, PA 15213 Phone: +1 (412) 268-2776 Email: [email protected] 1 Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract The composition of the cell nucleus is highly heterogeneous, with different constituents forming complex interactomes. However, the global patterns of these interwoven heterogeneous interactomes remain poorly understood. Here we focus on two different interactomes, chromatin interaction network and gene regulatory network, as a proof-of-principle, to identify heterogeneous interactome modules (HIMs), each of which represents a cluster of gene loci that are in spatial contact more frequently than expected and that are regulated by the same group of transcription factors. HIM integrates transcription factor binding and 3D genome structure to reflect “transcriptional niche” in the nucleus. We develop a new algorithm MOCHI to facilitate the discovery of HIMs based on network motif clustering in heterogeneous interactomes. By applying MOCHI to five different cell types, we found that HIMs have strong spatial preference within the nucleus and exhibit distinct functional properties. Through integrative analysis, this work demonstrates the utility of MOCHI to identify HIMs, which may provide new perspectives on the interplay between transcriptional regulation and 3D genome organization. -
Cpg Island Hypermethylation in Human Astrocytomas
Published OnlineFirst March 16, 2010; DOI: 10.1158/0008-5472.CAN-09-3631 Molecular and Cellular Pathobiology Cancer Research CpG Island Hypermethylation in Human Astrocytomas Xiwei Wu2, Tibor A. Rauch3, Xueyan Zhong1, William P. Bennett1, Farida Latif4, Dietmar Krex5, and Gerd P. Pfeifer1 Abstract Astrocytomas are common and lethal human brain tumors. We have analyzed the methylation status of over 28,000 CpG islands and 18,000 promoters in normal human brain and in astrocytomas of various grades using the methylated CpG island recovery assay. We identified 6,000 to 7,000 methylated CpG islands in normal human brain. Approximately 5% of the promoter-associated CpG islands in the normal brain are methylated. Promoter CpG island methylation is inversely correlated whereas intragenic methylation is directly correlated with gene expression levels in brain tissue. In astrocytomas, several hundred CpG islands undergo specific hy- permethylation relative to normal brain with 428 methylation peaks common to more than 25% of the tumors. Genes involved in brain development and neuronal differentiation, such as BMP4, POU4F3, GDNF, OTX2, NEFM, CNTN4, OTP, SIM1, FYN, EN1, CHAT, GSX2, NKX6-1, PAX6, RAX, and DLX2, were strongly enriched among genes frequently methylated in tumors. There was an overrepresentation of homeobox genes and 31% of the most commonly methylated genes represent targets of the Polycomb complex. We identified several chromosomal loci in which many (sometimes more than 20) consecutive CpG islands were hypermethylated in tumors. Seven such loci were near homeobox genes, including the HOXC and HOXD clusters, and the BARHL2, DLX1,and PITX2 genes. Two other clusters of hypermethylated islands were at sequences of recent gene duplication events. -
Epi)Genomics Data in the 3T9mycer, Eµ-Myc and Tet-MYC
PhD degree in Molecular Medicine (curriculum in Computational Biology) European School of Molecular Medicine (SEMM), University of Milan and University of Naples “Federico II” An integrative approach to identify binding partners of Myc using (epi)genomics data in the 3T9MycER, Eµ-myc and tet-MYC systems Pranami Bora Center for Genomic Science of IIT@SEMM, Milan Matricola n. R10337 Supervisor: Dr. Bruno Amati Center for Genomic Science of IIT@SEMM, Milan Added Supervisor: Dr. Marco Morelli Center for Genomic Science of IIT@SEMM, Milan Anno accademico 2016-2017 Table of Contents List of abbreviations ...................................................................................................... 4 Figures index ................................................................................................................. 5 Abstract ........................................................................................................................ 8 Chapter 1 ..................................................................................................................... 10 Introduction ................................................................................................................. 10 1.1 Epigenetics ............................................................................................................... 10 1.1.1 Acetylation and methylation ..................................................................................... 10 1.1.2 Transcription factors ................................................................................................. -
Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ...................................................... -
Prefrontal Co-Expression of Schizophrenia Risk Genes Is Associated with Treatment Response
bioRxiv preprint doi: https://doi.org/10.1101/323428; this version posted May 16, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title: Prefrontal co-expression of schizophrenia risk genes is associated with treatment response 2 in patients 3 4 One Sentence Summary: Schizophrenia risk genes co-expressed in the dorsolateral prefrontal cortex 5 are associated with clinical outcome in patients with schizophrenia. 6 7 Authors: Giulio Pergola1,†, Pasquale Di Carlo1,2,†, Andrew E. Jaffe2,3,4,5, Marco Papalino1, Qiang 8 Chen2, Thomas M. Hyde2,7,8, Joel E. Kleinman2,7, Joo Heon Shin2, Antonio Rampino1,10, Giuseppe 9 Blasi1,10, Daniel R. Weinberger2,6,8,9, Alessandro Bertolino1,10,* 10 11 Affiliations: 12 1Group of Psychiatric Neuroscience, Department of Basic Medical Sciences, Neuroscience and Sense 13 Organs, University of Bari Aldo Moro, Bari, Italy 14 2Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland, 15 USA 16 3Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, 17 Maryland, USA 18 4Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 19 USA 20 5Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, USA 21 6Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, Maryland, USA 22 7Department of Neurology, Johns Hopkins School of Medicine, Baltimore, 1 bioRxiv preprint doi: https://doi.org/10.1101/323428; this version posted May 16, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.